Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HPV vaccine in phase I at Merck & Co.

May 24, 1996

New finding may help in overcoming bacterial resistance

May 17, 1996

SKB and MicroCarb to collaborate on bacterial vaccines

May 17, 1996

Vical, Pasteur Merieux Connaught expand naked DNA vaccine collaboration

May 17, 1996

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...